STOCK TITAN

Cycclone Magnetic Engines Enters Work Order to Produce and Fit Y9XM Engine

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

China Dasheng Biotechnology Co. (OTC PINK:CDBT) announced a significant development with its subsidiary, Cycclone Magnetic Engines, securing a work order for the production of the new Y9XM engine.

Manufacturing will take place across three facilities in Australia. The initial target is to produce 50 engines for testing in stationary power applications, particularly for agricultural needs.

The company aims to achieve market certification and compliance for its engines, paving the way for future commercial opportunities. This advancement highlights CDBT's commitment to developing low-carbon emission technologies.

Positive
  • Cycclone Magnetic Engines signed a work order for manufacturing the Y9XM engine.
  • Production set to begin at three facilities in Australia.
  • Initial run of 50 engines will be produced for testing in agricultural applications.
  • Focus on low-carbon emission technologies indicates alignment with market trends.
Negative
  • None.

ARUNDEL QUEENSLAND, AUSTRALIA / ACCESSWIRE / February 20, 2023 / China Dasheng Biotechnology Co. (OTC PINK:CDBT) through controlled subsidiary Cycclone & Y Engine Developments Pty Ltd has signed a work order to manufacture, supply and fit a Y9XM new series engine into a vehicle.

China Dasheng Biotechnology Co., Monday, February 20, 2023, Press release picture

Cycclone Magnetic Engines operates across 3 facilities in Australia, Arundel, Queensland (administrative, patent development and base engineering), Bangalow, New South Wales (component development and product end fitment structure) and Molendinar, Queensland (CNC precision and short run production). Work has now commenced at the Bangalow facility to meet the work order.

Cycclone Magnetic Engines open plan is to develop and manufacture a short run of 50 engines for supply testing in non-essential use. Non-essential use is identified as stationary power plants in agricultural needs such as water pumping and other areas that allow for testing with possible disruption during use.

As a dedicated engine development company, Cycclone Magnetic Engines focus is to develop, produce, test and reach the milestone of certification and compliance for market sales. Once this milestone is met, potential clients will be canvassed to seek possible end use products.

/S/ Micheal Nugent
CEO of CDBT

# # #

CDBT. Cycclone Magnetic Engine Developments, Inc.

On September 30, 2022, CDBT and Cycclone Magnetic Engine Developments Limited entered into an Operating Agreement for The Amended Share Exchange Agreement giving effective control of Cycclone Magnetic Engine Developments Limited and the wholly owned subsidiaries.

Cycclone Magnetic Engine Developments Limited is engaged in the development and commercialization of new geometric configuration low carbon emission engines and other clean technology solutions with a view to create technologies that improve efficiency and reduce levels of greenhouse emissions. Cycclone has shareholding, assets and interests in transport operations in Australia. Cycclone Magnetic Engine Developments Limited operations are based in Australia.

Micheal Nugent
mnugent@nugent.com.au
www.cdbtcycclone.com
+61438158688

Safe Harbor Statement

Statements made in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995. Risk factors that could cause actual results to differ materially from those projected in forward-looking statements include, but are not limited to, general business conditions, managing growth, and political and other business risks.

SOURCE: China Dasheng Biotechnology Co.



View source version on accesswire.com:
https://www.accesswire.com/739950/Cycclone-Magnetic-Engines-Enters-Work-Order-to-Produce-and-Fit-Y9XM-Engine

FAQ

What is the recent work order signed by CDBT?

CDBT has signed a work order with its subsidiary Cycclone Magnetic Engines to manufacture the Y9XM engine.

Where will the Y9XM engine be manufactured?

The Y9XM engine will be manufactured across three facilities located in Queensland and New South Wales, Australia.

What is the purpose of producing the Y9XM engine?

The Y9XM engine is being produced for testing in non-essential applications, primarily for agricultural use like water pumping.

How many engines is CDBT planning to produce initially?

CDBT plans to produce an initial run of 50 engines for testing.

What are the future plans for CDBT's engine development?

CDBT aims to achieve certification and compliance for market sales of their engines following the testing phase.

CHINA DASHENG BIOTECH CO

OTC:CDBT

CDBT Rankings

CDBT Latest News

CDBT Stock Data

3.60M
25.17M
Shell Companies
Financial Services
United States of America
Lanzhou